These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36890170)

  • 41. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.
    Latour P; Thauvin-Robinet C; Baudelet-Méry C; Soichot P; Cusin V; Faivre L; Locatelli MC; Mayençon M; Sarcey A; Broussolle E; Camu W; David A; Rousson R
    Am J Hum Genet; 2010 Jan; 86(1):77-82. PubMed ID: 20045102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Charcot-Marie-Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation.
    Hamaguchi A; Ishida C; Iwasa K; Abe A; Yamada M
    J Neurol; 2010 Jul; 257(7):1202-4. PubMed ID: 20169446
    [No Abstract]   [Full Text] [Related]  

  • 43. A novel mutation of the glycyl-tRNA synthetase (GARS) gene associated with Charcot-Marie-Tooth type 2D in a Chinese family.
    Sun A; Liu X; Zheng M; Sun Q; Huang Y; Fan D
    Neurol Res; 2015 Sep; 37(9):782-7. PubMed ID: 26000875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A missense, loss-of-function
    Forrest ME; Meyer AP; Laureano Figueroa SM; Antonellis A
    Cold Spring Harb Mol Case Stud; 2022 Dec; 8(7):. PubMed ID: 36307205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel mutation in the GARS gene in a Malian family with Charcot-Marie-Tooth disease.
    Yalcouyé A; Diallo SH; Coulibaly T; Cissé L; Diallo S; Samassékou O; Diarra S; Coulibaly D; Keita M; Guinto CO; Fischbeck K; Landouré G;
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00782. PubMed ID: 31173493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conformational sampling of CMT-2D associated GlyRS mutations.
    Childers MC; Regnier M; Bothwell M; Smith AST
    Brain Multiphys; 2022; 3():. PubMed ID: 36504507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inherited neuropathies: new genes don't fit old models.
    Scherer SS
    Neuron; 2006 Sep; 51(6):672-4. PubMed ID: 16982409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.
    Antonellis A; Ellsworth RE; Sambuughin N; Puls I; Abel A; Lee-Lin SQ; Jordanova A; Kremensky I; Christodoulou K; Middleton LT; Sivakumar K; Ionasescu V; Funalot B; Vance JM; Goldfarb LG; Fischbeck KH; Green ED
    Am J Hum Genet; 2003 May; 72(5):1293-9. PubMed ID: 12690580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease.
    Nan H; Takaki R; Hata T; Ichinose Y; Tsuchiya M; Koh K; Takiyama Y
    J Peripher Nerv Syst; 2019 Mar; 24(1):156-160. PubMed ID: 30394614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel multisystem disease associated with recessive mutations in the tyrosyl-tRNA synthetase (YARS) gene.
    Nowaczyk MJ; Huang L; Tarnopolsky M; Schwartzentruber J; Majewski J; Bulman DE; ; Hartley T; Boycott KM
    Am J Med Genet A; 2017 Jan; 173(1):126-134. PubMed ID: 27633801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology.
    Grice SJ; Sleigh JN; Motley WW; Liu JL; Burgess RW; Talbot K; Cader MZ
    Hum Mol Genet; 2015 Aug; 24(15):4397-406. PubMed ID: 25972375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS.
    Sun L; Wei N; Kuhle B; Blocquel D; Novick S; Matuszek Z; Zhou H; He W; Zhang J; Weber T; Horvath R; Latour P; Pan T; Schimmel P; Griffin PR; Yang XL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystallization and preliminary X-ray analysis of a native human tRNA synthetase whose allelic variants are associated with Charcot-Marie-Tooth disease.
    Xie W; Schimmel P; Yang XL
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Dec; 62(Pt 12):1243-6. PubMed ID: 17142907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variants of aminoacyl-tRNA synthetase genes in Charcot-Marie-Tooth disease: A Korean cohort study.
    Nam DE; Park JH; Park CE; Jung NY; Nam SH; Kwon HM; Kim HS; Kim SB; Son WS; Choi BO; Chung KW
    J Peripher Nerv Syst; 2022 Mar; 27(1):38-49. PubMed ID: 34813128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy.
    Rhymes ER; Simkin RL; Qu J; Villarroel-Campos D; Surana S; Tong Y; Shapiro R; Burgess RW; Yang XL; Schiavo G; Sleigh JN
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of a dynamin 2 mutant associated with Charcot-Marie-Tooth disease leads to aberrant actin dynamics and lamellipodia formation.
    Yamada H; Kobayashi K; Zhang Y; Takeda T; Takei K
    Neurosci Lett; 2016 Aug; 628():179-85. PubMed ID: 27328317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
    Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
    Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The insertion domain 1 of class IIA dimeric glycyl-tRNA synthetase is a rubredoxin-like zinc ribbon.
    Kaur G; Subramanian S
    J Struct Biol; 2015 Apr; 190(1):38-46. PubMed ID: 25721219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent Advances in
    Kitani-Morii F; Noto YI
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.